GlassScriptPhysician profile
Mark H Mounayer
NPI 1073855383
$85,171.25
in general payments reported to CMS, 2019-2025
41 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,547 · 2020: $785 · 2021: $3,180 · 2022: $3,882 · 2023: $24K · 2024: $20K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $12K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,200.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,997.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,400.00 |
| Travel and Lodging | $12,080.57 |
| Food and Beverage | $11,099.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $43,499.52 | 2019-2024 | Senza |
| Globus Medical, INC. | $28,077.62 | 2025 | Senza, Sp-Fix, Zyfuse |
| Abbott Laboratories | $5,015.35 | 2019-2025 | Proclaim, Eterna, Infinity |
| Boston Scientific Corporation | $3,040.93 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Vertiflex, INC. | $1,830.43 | 2019 | |
| Medtronic USA, INC. | $387.56 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $366.62 | 2019-2023 | Ztlido |
| Medtronic, INC. | $349.20 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nalu Medical, INC. | $281.82 | 2023-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $252.10 | 2019-2024 | Relistor |
| Pfizer INC. | $229.13 | 2019-2025 | |
| Si-Bone, INC. | $171.67 | 2019-2025 | |
| Amgen INC. | $162.92 | 2023-2025 | Evenity, Prolia |
| Collegium Pharmaceutical, INC. | $155.37 | 2019-2022 | |
| Curonix LLC | $135.94 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mounayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.